Healthcare
Just 20% of tobacco sold in Australia is legal and nicotine use is on the rise. MPs from across the spectrum want sky high excise rates to be reconsidered.
The Sydney firm will open a US-based research institute and seek to make five to 10 business investments in the untapped peri- and post-menopause healthcare market.
Australia’s digital health sector is growing fast — but the companies building the next generation of regulated medical technologies say they are being cut off from the capital they need to survive.
The Tesla chair conducted a sweeping review of Australia’s R&D incentives. But even she didn’t expect the change in last week’s budget that has blindsided the biotech and deep tech sectors.
The fertility treatment provider, which has rejected takeover approaches from Soul Patts and Genesis Capital this year, is aiming to prevent a repeat of two high-profile embryo mix-ups.
A slew of ASX listed biotech and critical minerals names could lose millions due to changes in R&D incentives that have sparked concerns across the wider innovation community.
Treasurer Jim Chalmers is expected to hand down a budget including some of the Albanese government’s most ambitious gambits yet.
CEO Dig Howitt has conceded the ear implant manufacturer could be facing years of pain due to an ‘extreme’ decline in consumer sentiment, particularly in the US.
